Skin Cancer Oncology Radiation Evidence Registry

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

350 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-02-15

Study Completion Date

2021-05-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To collect and analyze long term safety and efficacy outcomes of patients undergoing radiotherapy for non-melanoma skin cancer. A target of 400 VMAT-treated sites is set which is estimated to be identified in approximately 350 participants. Participants referred for radiotherapy for the management of non-melanoma skin cancer.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Photon/Proton Radiation Therapy for Carcinoma of the Skin of the Head and Neck

NCT00797043

Malignant Neoplasm of Skin Head and Neck

TERMINATED

Stereotactic Body Radiation Therapy for Inoperable Non-metastasized Pancreatic Adenocarcinoma

NCT06691425

Non-metastasized Unresectable Pancreatic Carcinoma

RECRUITING NA

A Phase I/II Trial of Stereotactic Body Radiation Therapy

NCT00591838

Inoperable Stage I/II Non-small Cell Lung Cancer

COMPLETED PHASE1/PHASE2

Microwave Ablation With MRI-Guided SBRT Boost in Renal Cell Carcinoma

NCT02782715

Carcinoma, Renal Cell

TERMINATED PHASE1/PHASE2

Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer

NCT00960999

Lung Cancer

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Registry will collect information on key clinical indications and patient reported outcomes to assess the safety and efficacy of VMAT radiotherapy. Data that will be collected includes baseline data of demographic, relevant medical history, photographs, treatment schedule, and treatment outcomes. Data may be collected retrospectively in regard to previous relevant medical history, prior treatments and outcomes as well as prospectively, including treatment schedule and treatment outcomes of radiotherapy treatment.

The Registry aims to assess the safety and outcomes of treatment for up to 5 years. This Registry will be the first of its kind in the US and will provide a basis for a number of potential research publications. The Registry will also give insights into treatment delivery and potentially facilitate future improvements in patient care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-melanoma Skin Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

There is no medical intervention for the purposes of this Registry.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Over 18 years of age
* Diagnosed with a treatable non-melanoma skin cancer by referring medical practitioner
* Eligible to be treated using widefield (\>50cm2) VMAT radiotherapy as determined by RO
* Patient has provided written informed consent.